Phathom Pharmaceuticals Inc Ordinary shares PHAT
News
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients
Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024
Phathom Gets Expanded FDA OK of Voquezna in Non-Erosive GERD
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
Investors tempted by latest meme-stock rally should see these charts before jumping in
Phathom Pharmaceuticals Gets FDA Approval for Voquezna Treatment